{"disease":{"id":"non-melanoma-skin-cancers","name":"non melanoma skin cancers"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04842279","title":"FACE-Q in Facial Reconstructive Surgery: A Prospective Database","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT05086692","title":"A Beta-only IL-2 ImmunoTherapY Study","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":115,"lead_sponsor_name":"Medicenna Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05315128","title":"Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Zagazig University","has_results":false},{"nct_id":"NCT04470726","title":"Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"AiViva BioPharma, Inc.","has_results":false},{"nct_id":"NCT04160065","title":"Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"TuHURA Biosciences, Inc.","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}